Skip to main content
logo
DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
0.7190
+0.0016 (0.22%)
At close: Jul 11, 2025, 4:00 PM
0.6923
-0.0267 (-3.71%)
After-hours: Jul 11, 2025, 5:46 PM EDT

DarioHealth Revenue

DarioHealth had revenue of $6.75M in the quarter ending March 31, 2025, with 17.26% growth. This brings the company's revenue in the last twelve months to $28.03M, up 47.20% year-over-year. In the year 2024, DarioHealth had annual revenue of $27.04M with 32.86% growth.

Revenue (ttm)
$28.03M
Revenue Growth
+47.20%
P/S Ratio
1.34
Revenue / Employee
$138,782
Employees
202
Market Cap
31.97M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 27.04M 6.69M 32.86%
Dec 31, 2023 20.35M -7.30M -26.41%
Dec 31, 2022 27.66M 7.14M 34.82%
Dec 31, 2021 20.51M 12.94M 170.76%
Dec 31, 2020 7.58M 17.00K 0.22%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Eli Lilly and Company 49.00B
Novo Nordisk 43.92B
Revenue Rankings

DRIO News

More News